Loading...

Gopalan Sethuraman

TitleAssistant Professor of Research Neurology
InstitutionUniversity of Southern California
DepartmentNeurology
AddressATR 9860 Mesa Rim Road
Off Campus
San Diego CA 92121
Phone+1 858 964 0794
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Wang G, Berry S, Xiong C, Hassenstab J, Quintana M, McDade EM, Delmar P, Vestrucci M, Sethuraman G, Bateman RJ. A novel cognitive disease progression model for clinical trials in autosomal-dominant Alzheimer's disease. Stat Med. 2018 Sep 20; 37(21):3047-3055. PMID: 29761523.
      View in: PubMed
    2. Reed C, Belger M, Dell'Agnello G, Kahle-Wrobleski K, Sethuraman G, Hake A, Raskin J, Henley D. Representativeness of European clinical trial populations in mild Alzheimer's disease dementia: a comparison of 18-month outcomes with real-world data from the GERAS observational study. Alzheimers Res Ther. 2018 Apr 03; 10(1):36. PMID: 29615123.
      View in: PubMed
    3. Siemers ER, Sundell KL, Carlson C, Case M, Sethuraman G, Liu-Seifert H, Dowsett SA, Pontecorvo MJ, Dean RA, Demattos R. Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer's disease patients. Alzheimers Dement. 2016 Feb; 12(2):110-120. PMID: 26238576.
      View in: PubMed
    4. Liu-Seifert H, Siemers E, Holdridge KC, Andersen SW, Lipkovich I, Carlson C, Sethuraman G, Hoog S, Hayduk R, Doody R, Aisen P. Delayed-start analysis: Mild Alzheimer's disease patients in solanezumab trials, 3.5 years. Alzheimers Dement (N Y). 2015 Sep; 1(2):111-121. PMID: 29854931.
      View in: PubMed
    5. Doody RS, Raman R, Sperling RA, Seimers E, Sethuraman G, Mohs R, Farlow M, Iwatsubo T, Vellas B, Sun X, Ernstrom K, Thomas RG, Aisen PS. Peripheral and central effects of ?-secretase inhibition by semagacestat in Alzheimer's disease. Alzheimers Res Ther. 2015; 7(1):36. PMID: 26064192.
      View in: PubMed
    6. Henley DB, Sundell KL, Sethuraman G, Dowsett SA, May PC. Safety profile of semagacestat, a gamma-secretase inhibitor: IDENTITY trial findings. Curr Med Res Opin. 2014 Oct; 30(10):2021-32. PMID: 24983746.
      View in: PubMed
    7. Henley DB, Sundell KL, Sethuraman G, Schneider LS. Adverse events and dropouts in Alzheimer's disease studies: what can we learn? Alzheimers Dement. 2015 Jan; 11(1):24-31. PMID: 24613705.
      View in: PubMed
    8. Habteab Ghebretinsae A, Molenberghs G, Dmitrienko A, Offen W, Sethuraman G. Assessment of type I error rate associated with dose-group switching in a longitudinal Alzheimer trial. J Biopharm Stat. 2014; 24(3):660-84. PMID: 24697817.
      View in: PubMed
    9. Doody RS, Raman R, Farlow M, Iwatsubo T, Vellas B, Joffe S, Kieburtz K, He F, Sun X, Thomas RG, Aisen PS. A phase 3 trial of semagacestat for treatment of Alzheimer's disease. N Engl J Med. 2013 Jul 25; 369(4):341-50. PMID: 23883379.
      View in: PubMed
    10. Farlow M, Arnold SE, van Dyck CH, Aisen PS, Snider BJ, Porsteinsson AP, Friedrich S, Dean RA, Gonzales C, Sethuraman G, DeMattos RB, Mohs R, Paul SM, Siemers ER. Safety and biomarker effects of solanezumab in patients with Alzheimer's disease. Alzheimers Dement. 2012 Jul; 8(4):261-71. PMID: 22672770.
      View in: PubMed
    11. Yu P, Dean RA, Hall SD, Qi Y, Sethuraman G, Willis BA, Siemers ER, Martenyi F, Tauscher JT, Schwarz AJ. Enriching amnestic mild cognitive impairment populations for clinical trials: optimal combination of biomarkers to predict conversion to dementia. J Alzheimers Dis. 2012; 32(2):373-85. PMID: 22796873.
      View in: PubMed
    12. Henley DB, Sundell KL, Sethuraman G, Siemers ER. Safety profile of Alzheimer's disease populations in Alzheimer's Disease Neuroimaging Initiative and other 18-month studies. Alzheimers Dement. 2012 Sep; 8(5):407-16. PMID: 22138370.
      View in: PubMed
    13. Lachno DR, Romeo MJ, Siemers ER, Vanderstichele H, Coart E, Konrad RJ, Zajac JJ, Talbot JA, Jensen HF, Sethuraman G, Demattos RB, May PC, Dean RA. Validation of ELISA methods for quantification of total tau and phosporylated-tau181 in human cerebrospinal fluid with measurement in specimens from two Alzheimer's disease studies. J Alzheimers Dis. 2011; 26(3):531-41. PMID: 21694458.
      View in: PubMed
    14. Kane JM, Detke HC, Naber D, Sethuraman G, Lin DY, Bergstrom RF, McDonnell D. Olanzapine long-acting injection: a 24-week, randomized, double-blind trial of maintenance treatment in patients with schizophrenia. Am J Psychiatry. 2010 Feb; 167(2):181-9. PMID: 20008947.
      View in: PubMed
    15. Reaven GM, Lieberman JA, Sethuraman G, Kraemer H, Davis JM, Blasey C, Tsuang MT, Schatzberg AF. In search of moderators and mediators of hyperglycemia with atypical antipsychotic treatment. J Psychiatr Res. 2009 Jul; 43(11):997-1002. PMID: 19268968.
      View in: PubMed
    16. Dunayevich E, Sethuraman G, Enerson M, Taylor CC, Lin D. Characteristics of two alternative schizophrenia remission definitions: relationship to clinical and quality of life outcomes. Schizophr Res. 2006 Sep; 86(1-3):300-8. PMID: 16860974.
      View in: PubMed
    17. Sethuraman G, Taylor CC, Enerson M, Dunayevich E. Response to Kujawa et al. letter-to-the-editor. Schizophr Res. 2006 May; 84(1):172-3. PMID: 16563702.
      View in: PubMed
    18. Franz DN, Leonard J, Tudor C, Chuck G, Care M, Sethuraman G, Dinopoulos A, Thomas G, Crone KR. Rapamycin causes regression of astrocytomas in tuberous sclerosis complex. Ann Neurol. 2006 Mar; 59(3):490-8. PMID: 16453317.
      View in: PubMed
    19. Beasley CM, Sutton VK, Taylor CC, Sethuraman G, Dossenbach M, Naber D. Is quality of life among minimally symptomatic patients with schizophrenia better following withdrawal or continuation of antipsychotic treatment? J Clin Psychopharmacol. 2006 Feb; 26(1):40-4. PMID: 16415704.
      View in: PubMed
    20. Barzman DH, McConville BJ, Masterson B, McElroy S, Sethuraman G, Moore K, Kahwaty AM, Nelson D. Impulsive aggression with irritability and responsive to divalproex: a pediatric bipolar spectrum disorder phenotype? J Affect Disord. 2005 Nov; 88(3):279-85. PMID: 16169087.
      View in: PubMed
    21. Joiner TE, Brown JS, Perez M, Sethuraman G, Sallee FR. The illusion of mental health: in the mind of which beholder? J Pers Assess. 2005 Aug; 85(1):92-7. PMID: 16083388.
      View in: PubMed
    22. Sethuraman G, Taylor CC, Enerson M, Dunayevich E. A retrospective comparison of cumulative time spent in remission during treatment with olanzapine or risperidone among patients with schizophrenia. Schizophr Res. 2005 Nov 15; 79(2-3):337-40. PMID: 16054802.
      View in: PubMed
    23. Jazieh AR, Kopp M, Foraida M, Ghouse M, Khalil M, Savidge M, Sethuraman G. The use of dietary supplements by veterans with cancer. J Altern Complement Med. 2004 Jun; 10(3):560-4. PMID: 15253863.
      View in: PubMed
    24. Chae JH, Nahas Z, Wassermann E, Li X, Sethuraman G, Gilbert D, Sallee FR, George MS. A pilot safety study of repetitive transcranial magnetic stimulation (rTMS) in Tourette's syndrome. Cogn Behav Neurol. 2004 Jun; 17(2):109-17. PMID: 15453520.
      View in: PubMed
    25. Geraghty SR, Pinney SM, Sethuraman G, Roy-Chaudhury A, Kalkwarf HJ. Breast milk feeding rates of mothers of multiples compared to mothers of singletons. Ambul Pediatr. 2004 May-Jun; 4(3):226-31. PMID: 15153054.
      View in: PubMed
    26. Gilbert DL, Bansal AS, Sethuraman G, Sallee FR, Zhang J, Lipps T, Wassermann EM. Association of cortical disinhibition with tic, ADHD, and OCD severity in Tourette syndrome. Mov Disord. 2004 Apr; 19(4):416-25. PMID: 15077239.
      View in: PubMed
    27. Gilbert DL, Batterson JR, Sethuraman G, Sallee FR. Tic reduction with risperidone versus pimozide in a randomized, double-blind, crossover trial. J Am Acad Child Adolesc Psychiatry. 2004 Feb; 43(2):206-14. PMID: 14726728.
      View in: PubMed
    28. Buell JF, Trofe J, Sethuraman G, Hanaway MJ, Beebe TM, Gross TG, Alloway R, First MR, Woodle ES. Donors with central nervous system malignancies: are they truly safe? Transplantation. 2003 Jul 27; 76(2):340-3. PMID: 12883189.
      View in: PubMed
    29. Brehm BJ, Rourke KM, Cassell C, Sethuraman G. Psychosocial outcomes of a pilot multidisciplinary program for weight management. Am J Health Behav. 2003 Jul-Aug; 27(4):348-54. PMID: 12882428.
      View in: PubMed
    30. Kowatch RA, Sethuraman G, Hume JH, Kromelis M, Weinberg WA. Combination pharmacotherapy in children and adolescents with bipolar disorder. Biol Psychiatry. 2003 Jun 01; 53(11):978-84. PMID: 12788243.
      View in: PubMed
    31. Malik IA, Aziz Z, Zaidi SH, Sethuraman G. Gemcitabine and Cisplatin is a highly effective combination chemotherapy in patients with advanced cancer of the gallbladder. Am J Clin Oncol. 2003 Apr; 26(2):174-7. PMID: 12714891.
      View in: PubMed
    32. Rourke KM, Brehm BJ, Cassell C, Sethuraman G. Effect of weight change on bone mass in female adolescents. J Am Diet Assoc. 2003 Mar; 103(3):369-72. PMID: 12616262.
      View in: PubMed
    33. Gilbert DL, Sethuraman G, Kotagal U, Buncher CR. Meta-analysis of EEG test performance shows wide variation among studies. Neurology. 2003 Feb 25; 60(4):564-70. PMID: 12601093.
      View in: PubMed
    34. Upadhyaya HP, Brady KT, Liao J, Sethuraman G, Middaugh L, Wharton M, Sallee FR. Neuroendocrine and behavioral responses to dopaminergic agonists in adolescents with alcohol abuse. Psychopharmacology (Berl). 2003 Mar; 166(2):95-101. PMID: 12520313.
      View in: PubMed
    35. Rohatgi N, LaRocca RV, Bard V, Sethuraman G, Foon KA. Phase II trial of sequential therapy with fludarabine followed by cyclophosphamide, mitoxantrone, vincristine, and prednisone for low-grade follicular lymphomas. Am J Hematol. 2002 Jul; 70(3):181-5. PMID: 12111762.
      View in: PubMed
    36. McCormack F, Brody A, Meyer C, Leonard J, Chuck G, Dabora S, Sethuraman G, Colby TV, Kwiatkowski DJ, Franz DN. Pulmonary cysts consistent with lymphangioleiomyomatosis are common in women with tuberous sclerosis: genetic and radiographic analysis. Chest. 2002 Mar; 121(3 Suppl):61S. PMID: 11893688.
      View in: PubMed
    37. Sallee FR, Vrindavanam NS, Liu H, Sethuraman G, Sine L. Fenfluramine challenge in anxious children. Hum Psychopharmacol. 2000 Dec; 15(8):619-629. PMID: 12404615.
      View in: PubMed
    Gopalan's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _